News

PRESS RELEASE - Toulouse, France - May 2022 Dr. Florent Ginhoux joins Genoskin’s Scientific Advisory Board Genoskin is thrilled to welcome Dr. Florent Ginhoux, PhD, to its Scientific Advisory Board (SAB). After last year's nomination of world-renowned immunology expert, Dr. Nicolas Gaudenzio, as Genoskin’s CSO, Dr. Ginhoux will now bring his world-class expertise as Highly Cited Researcher in tissue-resident immuneRead more

Top-level science through the eyes of an expert.The second Webinar. The second webinar in the Naked Immunology series took place on May 10, 2022 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Highly Cited Researcher and immunology expert, Dr. Florent Ginhoux. watch theRead more

Top-level science through the eyes of an expert.The first Webinar. The first webinar in the Naked Immunology series took place on March 9, 2022 at 5:00 PM (CET) - 11 AM (EST) and is open to English-speaking participants with a solid scientific background. Featured speaker is globally renowned immunology expert Dr. Nicolas Gaudenzio. watch the replay Mast cells are tissue-residentRead more

Article by Pascal Descargues, first published in Life Science Leader on February 1, 2022. The original article is available here. What I Learned In A French Lab That Led To My Role As CEO The Path to the Aha Moment In 2006, I had just finished my Ph.D. in human pathophysiology, and I was working in a lab in Toulouse,Read more

GENOSKIN CSO OBTAINS HIGH-PROFILE CAREER AWARD To start the new year in good cheer, Genoskin is proud to announce that Dr. Nicolas Gaudenzio, our Chief Scientific Officer and Principal Investigator at Infinity, has recently obtained the Arloing-Courmont-Pasteur Institute career achievement award in human biology from the Academy of Science in Lyon, France. An award to highlight innovative scientific research TheRead more

CREATING BETTER TECHNOLOGY FOR RELIABLE DRUG DEVELOPMENT STUDIES Changing drug development as we know it Genoskin aims to change drug development technology as we know it. We combine artificial intelligence and cutting-edge technology with live ex vivo human tissue to efficiently help pharmaceutical and biotech companies develop new drugs and vaccines in a better, faster and more cost-efficient way. AndRead more